CN110787231A - Traditional Chinese medicine preparation for treating calculus and preparation method thereof - Google Patents
Traditional Chinese medicine preparation for treating calculus and preparation method thereof Download PDFInfo
- Publication number
- CN110787231A CN110787231A CN201911178239.7A CN201911178239A CN110787231A CN 110787231 A CN110787231 A CN 110787231A CN 201911178239 A CN201911178239 A CN 201911178239A CN 110787231 A CN110787231 A CN 110787231A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- herb
- medicine preparation
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating calculi, which comprises the following components in parts by weight: 50-100g of fossil grass, 50-100g of pyrrosia lingua, 50-100g of longhairy antenoron herb, 50-100g of motherwort herb, 50-100g of swertia mileensis, 50-100g of plantain herb, 70-100g of dandelion, 45-100g of bristlegrass, 30-100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli. The invention provides a medicine for treating calculi, which has no sugar or little sugar for diabetics and can achieve the effect of curing.
Description
Technical Field
The invention relates to the technical field of Chinese patent medicine products, in particular to a Chinese medicinal preparation for treating calculi and a preparation method thereof.
Background
Calculus refers to a solid mass formed in a lumen of a catheter or a lumen of a luminal organ within the human body. It is mainly found in gallbladder, bladder and renal pelvis, and also in pancreatic duct, salivary duct, etc. Calculus is composed of inorganic salts or organic substances. The stone generally has a core consisting of exfoliated epithelial cells, bacterial mass, parasite eggs or bodies, fecal mass or foreign matter, and inorganic salts or organic matter deposited layer by layer on the core.
Bile acid, phospholipid and cholesterol in human bile are kept in a certain proportion, and meanwhile, crystal polymerization inhibiting factors also exist in the bile, so that no calculus is formed in the gall bladder. Once this equilibrium is disrupted by some factor, it can lead to the formation of cholesterol crystals within the gallbladder, ultimately resulting in gallstones. Metabolic abnormalities of the body, obstruction of the urinary tract, infection, foreign bodies and the use of drugs are common causes of kidney stone formation. Once calculus is formed, the removal of liquid in the affected organ can be affected, pain, bleeding, infection and the like are caused, and the pain is brought to the daily life of a patient.
At present, calculus is generally treated mainly by calculus breaking and operation, and most of calculus breaking and contraindications are caused; the operation is large in wound and high in recurrence rate, and the blood glucose level before the operation is controlled for the diabetic, so that the operation is more complicated. Therefore, a medicine for treating lithiasis, particularly lithiasis in diabetes patients, is developed.
Disclosure of Invention
Aiming at the technical problems, the invention provides a traditional Chinese medicine preparation for treating calculi and a preparation method thereof. To solve the problem of medication for patients with diabetes and patients with calculus.
The invention provides a traditional Chinese medicine preparation for treating calculi, which comprises the following components in parts by weight:
50-100g of fossil grass, 50-100g of pyrrosia lingua, 50-100g of longhairy antenoron herb, 50-100g of motherwort herb, 50-100g of swertia mileensis, 50-100g of plantain herb, 70-100g of dandelion, 45-100g of bristlegrass, 30-100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
Preferably, the traditional Chinese medicine preparation comprises the following components in parts by weight: 100g of fossil grass, 100g of pyrrosia lingua, 100g of longhairy antenoron herb, 100g of motherwort herb, 100g of swertia mileensis, 100g of plantain herb, 100g of dandelion, 100g of bristlegrass, 100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
The invention also provides a method for preparing the traditional Chinese medicine preparation for treating calculi, which comprises the following steps:
(1) cleaning, drying and crushing the raw materials;
(2) and (2) uniformly mixing the raw material powder prepared in the step (1) according to the formula amount, and sieving by using a 100-mesh sieve to obtain a mixture, and pressing the mixture into tablets.
Preferably, the clinically-acceptable dosage form is oral liquid, tablets, capsules, granules, powder or pills.
Preferably, one bottle of 100 medicine granules with 0.4g is taken with warm water for one treatment course.
Advantageous effects
The traditional Chinese medicine preparation for treating calculi comprises the following components in pharmacological effect:
through processing and synthesizing various traditional Chinese medicines, the medicine has the functions of treating calculi and removing calculi, mainly treats kidney calculi, urethral calculi, vesical calculi, gallstone and the like,
after the prescription is used by patients with hypertension, hypertension and hyperlipidemia, the dosage needs to be reduced or stopped.
The composition for treating calculi can be used as an effective active ingredient of a medicine, and the weight percentage of the composition in the medicine can be properly adjusted according to clinical needs (such as the range of 0.1-99.9 percent).
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the following detailed description, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the case of medication, the patient is diabetic, and due to the particularity of the physical characteristics of the diabetic, the medication needs less sugar and no sugar.
The embodiment of the invention relates to a traditional Chinese medicine preparation for treating calculi, which comprises the following components in parts by weight:
50-100g of fossil grass, 50-100g of pyrrosia lingua, 50-100g of longhairy antenoron herb, 50-100g of motherwort herb, 50-100g of swertia mileensis, 50-100g of plantain herb, 70-100g of dandelion, 45-100g of bristlegrass, 30-100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
Further, the traditional Chinese medicine preparation comprises the following components in parts by weight: 100g of fossil grass, 100g of pyrrosia lingua, 100g of longhairy antenoron herb, 100g of motherwort herb, 100g of swertia mileensis, 100g of plantain herb, 100g of dandelion, 100g of bristlegrass, 100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
The method of the traditional Chinese medicine preparation for treating the calculi comprises the following steps:
(1) cleaning, drying and crushing the raw materials;
(2) and (2) uniformly mixing the raw material powder prepared in the step (1) according to the formula amount, and sieving by using a 100-mesh sieve to obtain a mixture, and pressing the mixture into tablets.
The clinically acceptable dosage form is oral liquid, tablets, capsules, granules, powder or pills.
Each medicine is 0.4g, 100 bottles and taken with warm water for one treatment course.
Typical cases
Yellow women: in 55 years old, patients with type 2 diabetes and patients with kidney stones are not well treated after eating other calculus-removing medicines for 2 and half years. After the preparation of the invention is taken for 45 days, the recovery is realized.
Golden lady: after the age of 45, the patient suffers from secondary diabetes and kidney stone for 1 and a half years, and cannot be treated well after eating other stone-removing medicines for a long time. After the preparation of the invention is taken for 33 days, the reexamination of the calculus is obviously reduced.
Peng and Mr. Cheng: in the age of 64, patients with type 1 diabetes and patients with kidney stones are not well treated after eating other calculus-removing medicines for 2 and half years. After the preparation of the invention is taken for 45 days, the recovery is realized.
The present invention is not limited to the above-described embodiments, and various modifications and variations of the present invention are intended to be included within the scope of the claims and the equivalent technology of the present invention if they do not depart from the spirit and scope of the present invention.
Claims (5)
1. The traditional Chinese medicine preparation for treating calculi is characterized by comprising the following components in parts by weight: 50-100g of fossil grass, 50-100g of pyrrosia lingua, 50-100g of longhairy antenoron herb, 50-100g of motherwort herb, 50-100g of swertia mileensis, 50-100g of plantain herb, 70-100g of dandelion, 45-100g of bristlegrass, 30-100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
2. The traditional Chinese medicine preparation for treating calculi according to claim 1, which is characterized by comprising the following components in parts by weight: 100g of fossil grass, 100g of pyrrosia lingua, 100g of longhairy antenoron herb, 100g of motherwort herb, 100g of swertia mileensis, 100g of plantain herb, 100g of dandelion, 100g of bristlegrass, 100g of lygodium japonicum and 500g of endothelium corneum gigeriae galli.
3. A method for preparing the traditional Chinese medicine preparation for treating calculi according to any one of claims 1 to 2, which is characterized by comprising the following steps:
(1) cleaning, drying and crushing the raw materials;
(2) and (2) uniformly mixing the raw material powder prepared in the step (1) according to the formula amount, and sieving by using a 100-mesh sieve to obtain a mixture, and pressing the mixture into tablets.
4. The preparation method of the traditional Chinese medicine preparation for treating calculi according to claim 3 is characterized in that: the clinically acceptable dosage form is tablets, capsules, granules, powder or pills.
5. The application of the traditional Chinese medicine preparation for treating calculi in claim 1 is characterized in that: each medicine is 0.4g, and 100 bottles are taken with warm water for one treatment course.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911178239.7A CN110787231A (en) | 2019-11-27 | 2019-11-27 | Traditional Chinese medicine preparation for treating calculus and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911178239.7A CN110787231A (en) | 2019-11-27 | 2019-11-27 | Traditional Chinese medicine preparation for treating calculus and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110787231A true CN110787231A (en) | 2020-02-14 |
Family
ID=69446437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911178239.7A Pending CN110787231A (en) | 2019-11-27 | 2019-11-27 | Traditional Chinese medicine preparation for treating calculus and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110787231A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412639A (en) * | 2015-12-01 | 2016-03-23 | 古东晖 | Medicine composition for treating calculus and preparing method thereof |
| CN109276583A (en) * | 2017-07-21 | 2019-01-29 | 姚庆诚 | The prescription of one group for the treatment of stone in urinary system |
-
2019
- 2019-11-27 CN CN201911178239.7A patent/CN110787231A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412639A (en) * | 2015-12-01 | 2016-03-23 | 古东晖 | Medicine composition for treating calculus and preparing method thereof |
| CN109276583A (en) * | 2017-07-21 | 2019-01-29 | 姚庆诚 | The prescription of one group for the treatment of stone in urinary system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109718273B (en) | Application of perilla leaf extract in preventing or treating osteoarthritis | |
| RU2281781C1 (en) | Agent for treatment of urolithiasis | |
| CN102846667A (en) | Preparation method for nanometer Periplaneta americana through low temperature drying | |
| CN108354898A (en) | A kind of Percutaneously administrable preparation and preparation method thereof for treating rheumatoid arthritis | |
| CN104042720A (en) | Traditional Chinese medicine for preventing and treating diabetes with depression and application of traditional Chinese medicine | |
| CN110787231A (en) | Traditional Chinese medicine preparation for treating calculus and preparation method thereof | |
| CN110200926A (en) | Composite reactive freeze-dried powder and its preparation method and application | |
| CN112691114B (en) | Application of momordica polysaccharide in preparation of medicine for treating ulcerative colitis and pharmaceutical preparation of momordica polysaccharide | |
| RU2342955C1 (en) | Method of antiseptic film obtaining | |
| CN100360161C (en) | Chinese medicine for treating diabets and nephritis | |
| CN102836152B (en) | Application of physalin B in preparation of medicine for curing and/or preventing schistosomiasis | |
| CN107260780B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN1089602C (en) | Medicinal composition for treating bone fracture and its preparing process | |
| CN1284594C (en) | Compound Chinese medicine prepn for treating benign prostate hyperplasia and its prepn process | |
| CN111991553B (en) | Medicine for treating nerve injury pain and application thereof | |
| CN108888664A (en) | A kind of Chinese traditional medicine composition for treating calculus | |
| CN103285040A (en) | Method for preparing nano periplaneta americana | |
| CN113425713B (en) | Pharmaceutical composition for treating duodenal ulcer | |
| CN111643498B (en) | Pharmaceutical composition for treating kidney stone and application thereof | |
| CN100339121C (en) | Chinese medicine for treating calculus | |
| RU2122418C1 (en) | Agent for treatment of patients with chronic hepatitis of an infectious etiology | |
| CN1179745C (en) | Chinese medicine preparation for curing choleithiasis and cholecystitis and production method thereof | |
| CN1883541A (en) | A Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease, its preparation method and use | |
| CN105287850A (en) | Walnut enzyme nutrient solution and preparation method thereof | |
| CN114948989A (en) | Application of magnesium hydride in preparing medicine for preventing and treating kidney crystal lithiasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200214 |
|
| RJ01 | Rejection of invention patent application after publication |